Since the MATE-ACT took effect in June 2023, health care clinicians have been encouraged to incorporate Buprenorphine into clinical practice for persons with Opioid Use Disorders and/or Chronic Pain. In these 3 sessions, we will explain why and how buprenorphine use as a continuous medication is on the climb in many clinical and hospital settings and explore future uses currently being evaluated in clinical research.
Participation is free. Pre-registration is required.
SESSION DATE
MAY 27 | NOON-1PM CST
The Role of Buprenorphine in the Clinical Setting: Latest research on buprenorphine use in other medical conditions
